{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:33:32Z","timestamp":1788878012802,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["PCS-1511-32745 and DI-2022C3-29701"],"award-info":[{"award-number":["PCS-1511-32745 and DI-2022C3-29701"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001473","name":"AO North America","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001473","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>To compare the effectiveness and safety of aspirin versus low-molecular-weight heparin (LMWH) for thromboprophylaxis in 11 high-risk or fracture location subpopulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A post hoc secondary analysis of the published PREVENT CLOT trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>21 trauma centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient Selection Criteria:<\/jats:title>\n                    <jats:p>Adult patients with an operatively treated extremity fracture or any pelvic or acetabular fracture were enrolled from April 2017 through August 2021. Patients with only hand or foot fractures, presenting &gt;48 hours after injury, or with a history of venous thromboembolism within 6 months of injury were excluded. The 11 subpopulations included (1) head injury, (2) abdominal injury, (3) spinal injury, (4) thoracic injury, (5) multiply injured patients, (6) obesity, (7) previous venous thromboembolism \u22656 months, (8) isolated upper extremity fracture, (9) isolated lower extremity fracture, (10) isolated pelvic or acetabular fracture, and (11) geriatric femur fracture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome Measures and Comparisons:<\/jats:title>\n                    <jats:p>The primary outcome was 90-day all-cause mortality. Secondary outcomes included nonfatal pulmonary embolism, proximal deep vein thrombosis (DVT), distal DVT, and bleeding events. Outcomes were assessed using Kaplan\u2013Meier estimators and Cox proportional hazards models comparing 81 mg of aspirin versus 30 mg of LMWH twice daily. The threshold for statistical significance was a Bonferroni-corrected alpha of 0.001 to account for multiple comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The largest subpopulations were isolated lower extremity fractures (n = 6289), obesity (n = 4234), and polytrauma with Injury Severity Score (ISS) &gt;16 (n = 1596). No comparison of aspirin versus LMWH within the 11 subpopulations for the 5 outcomes reached the corrected threshold for statistical significance of\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001. However, 5 comparisons of aspirin versus LMWH were less than the conventional\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value of 0.05. Specifically, the aspirin group demonstrated lower mortality in patients with a head injury (difference, \u22123.2%; 95% CI \u22126.1% to \u22120.3%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03) or a spine injury (difference, \u22126.0%; 95% CI \u221211.7% to \u22120.3%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04) than the LMWH group. The LMWH group demonstrated a lower rate of distal DVTs for patients with a head injury (difference, 4.4%; 95% CI, 0.8% to 8.1%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02), thoracic injury (difference, 1.5%; 95% CI, 0.0% to 2.9%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04) or with ISS &gt;16 (difference, 1.7%; 95% CI, 0.2% to 3.3;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03) than the aspirin group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      Within 11 high-risk or fracture location-specific subpopulations, there were no statistically significant differences between aspirin and LMWH in the 90-day rates of all-cause mortality, nonfatal PE, proximal DVT, distal DVT, or bleeding complications at a threshold corrected for multiple comparisons (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bot.0000000000003094","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T19:00:33Z","timestamp":1759863633000},"page":"22-29","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Aspirin Versus Low-Molecular-Weight Heparin for Thromboprophylaxis in High-Risk and Fracture Location Subpopulations: A Secondary Analysis of the PREVENT CLOT Trial"],"prefix":"10.1097","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0532-5552","authenticated-orcid":false,"given":"Sandip P.","family":"Tarpada","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0537-3474","authenticated-orcid":false,"given":"Nathan N.","family":"O'Hara","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Stein","sequence":"additional","affiliation":[{"name":"Program in Trauma\/Department of Surgery, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, MD, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0746-8605","authenticated-orcid":false,"given":"Anthony J.","family":"DeSantis","sequence":"additional","affiliation":[{"name":"Program in Trauma\/Department of Surgery, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, MD, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan C.","family":"Castillo","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5305-1774","authenticated-orcid":false,"given":"Katherine P.","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9111-9239","authenticated-orcid":false,"given":"Gerard P.","family":"Slobogean","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Leah","family":"Gitajn","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Dartmouth Hitchcock Medical Center, Lebanon, NH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2795-4029","authenticated-orcid":false,"given":"Greg E.","family":"Gaski","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Inova Fairfax Medical Campus, Fairfax, VA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2185-9730","authenticated-orcid":false,"given":"Laurence B.","family":"Kempton","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Carolinas Medical Center, Atrium Health Musculoskeletal Institute, Charlotte, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2113-9146","authenticated-orcid":false,"given":"Conor P.","family":"Kleweno","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery and Sports Medicine, Harborview Medical Center at the University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-489X","authenticated-orcid":false,"given":"Reza","family":"Firoozabadi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery and Sports Medicine, Harborview Medical Center at the University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-6841","authenticated-orcid":false,"given":"Joseph","family":"Cuschieri","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Britton","family":"Christmas","sequence":"additional","affiliation":[{"name":"Department of Surgery, Atrium Health-Carolinas Medical Center, Charlotte, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery A.","family":"Claridge","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Cleveland Clinic Health Care System, Cleveland, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0983-8630","authenticated-orcid":false,"given":"Debra","family":"Marvel","sequence":"additional","affiliation":[{"name":"PREVENT CLOT Patient Stakeholder."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"O'Toole","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"METRC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251212","first-page":"CD008303","article-title":"Thromboprophylaxis for trauma patients","volume":"2013","author":"Barrera","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-20251212","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"R3-20251212","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1097\/BOT.0000000000000387","article-title":"Venous thromboembolism prophylaxis in orthopaedic trauma patients: a survey of OTA member practice patterns and OTA expert panel recommendations","volume":"29","author":"Sagi","year":"2015","journal-title":"J Orthop Trauma"},{"key":"R4-20251212","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1055\/s-0037-1615817","article-title":"A systematic review on the use of aspirin in the prevention of deep vein thrombosis in major elective lower limb orthopedic surgery: an update from the past 3 years","volume":"3","author":"Mistry","year":"2017","journal-title":"Surg J (Ny)"},{"key":"R5-20251212","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2106\/JBJS.21.00168","article-title":"Aspirin is an effective prophylaxis for venous thromboembolism in ambulatory patients with femoral neck fracture undergoing hip arthroplasty","volume":"104","author":"Chisari","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"R6-20251212","doi-asserted-by":"crossref","first-page":"e016676","DOI":"10.1136\/bmjopen-2017-016676","article-title":"Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment","volume":"7","author":"Haac","year":"2017","journal-title":"BMJ Open"},{"key":"R7-20251212","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2205973","article-title":"Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture","volume":"388","author":"O'Toole","year":"2023","journal-title":"N Engl J Med"},{"key":"R8-20251212","doi-asserted-by":"crossref","first-page":"e041845","DOI":"10.1136\/bmjopen-2020-041845","article-title":"PREVENTion of CLots in orthopaedic trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients","volume":"11","author":"O'Toole","year":"2021","journal-title":"BMJ Open"},{"key":"R9-20251212","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-158-11-201306040-00004","article-title":"Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial","volume":"158","author":"Anderson","year":"2013","journal-title":"Ann Intern Med"},{"key":"R10-20251212","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005373-199701000-00017","article-title":"Posttrauma thromboembolism prophylaxis","volume":"42","author":"Greenfield","year":"1997","journal-title":"J Trauma"},{"key":"R11-20251212","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/TA.0b013e3182588b54","article-title":"Determining venous thromboembolic risk assessment for patients with trauma: the trauma embolic scoring system","volume":"73","author":"Rogers","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"R12-20251212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5435\/JAAOS-23-01-1","article-title":"Venous thromboembolism in orthopaedic trauma","volume":"23","author":"Scolaro","year":"2015","journal-title":"J Am Acad Orthop Surg"},{"key":"R13-20251212","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/TA.0000000000000294","article-title":"Isolated traumatic brain injury and venous thromboembolism","volume":"77","author":"Van Gent","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"R14-20251212","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jss.2022.10.003","article-title":"Thromboprophylaxis timing after blunt solid organ injury: a systematic review and meta-analysis","volume":"282","author":"Anteby","year":"2023","journal-title":"J Surg Res"},{"key":"R15-20251212","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/TA.0000000000003807","article-title":"Venous thromboembolism risk after spinal cord injury: a secondary analysis of the CLOTT study","volume":"94","author":"Godat","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"key":"R16-20251212","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.3928\/01477447-20140528-50","article-title":"Multiple lower-extremity and pelvic fractures increase pulmonary embolus risk","volume":"37","author":"Godzik","year":"2014","journal-title":"Orthopedics"},{"key":"R17-20251212","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jss.2020.05.008","article-title":"Venous thromboembolism in geriatric trauma patients\u2014risk factors and associated outcomes","volume":"254","author":"Prabhakaran","year":"2020","journal-title":"J Surg Res"},{"key":"R18-20251212","doi-asserted-by":"crossref","first-page":"111523","DOI":"10.1016\/j.injury.2024.111523","article-title":"Propensity weighted analysis of chemical venous thromboembolism prophylaxis agents in isolated severe traumatic brain injury: an EAST sponsored multicenter study","volume":"55","author":"Ratnasekera","year":"2024","journal-title":"Injury"},{"key":"R19-20251212","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/s-0034-1398386","article-title":"Venous thromboembolism prophylaxis in critically ill patients","volume":"41","author":"Boonyawat","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"R20-20251212","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.amjsurg.2013.12.010","article-title":"A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients","volume":"207","author":"Gritsiouk","year":"2014","journal-title":"Am J Surg"},{"key":"R21-20251212","doi-asserted-by":"crossref","first-page":"e000643","DOI":"10.1136\/tsaco-2020-000643","article-title":"Venous thromboembolism prophylaxis in the trauma intensive care unit: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document","volume":"6","author":"Rappold","year":"2021","journal-title":"Trauma Surg Acute Care Open"},{"key":"R22-20251212","doi-asserted-by":"crossref","first-page":"e1004176","DOI":"10.1371\/journal.pmed.1004176","article-title":"Treatment effect modification due to comorbidity: individual participant data meta-analyses of 120 randomised controlled trials","volume":"20","author":"Hanlon","year":"2023","journal-title":"PLOS Med"},{"key":"R23-20251212","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TA.0000000000004226","article-title":"Risk-stratified thromboprophylaxis effects of aspirin versus low-molecular-weight heparin in orthopedic trauma patients: a secondary analysis of the PREVENT CLOT trial","volume":"96","author":"O'Hara","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"R24-20251212","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2106\/JBJS.23.00824","article-title":"Effect of aspirin versus low-molecular-weight heparin thromboprophylaxis on medication satisfaction and out-of-pocket costs: a secondary analysis of a randomized clinical trial","volume":"106","author":"O'Hara","year":"2024","journal-title":"J Bone Joint Surg Am"},{"key":"R25-20251212","first-page":"1436","article-title":"Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis","volume":"66","author":"Reiff","year":"2009","journal-title":"J Trauma"},{"key":"R26-20251212","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13054-015-1003-9","article-title":"Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis","volume":"19","author":"Minet","year":"2015","journal-title":"Crit Care"},{"key":"R27-20251212","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjsurg.2023.07.041","article-title":"Below the knee, let it be: management of calf DVT in hospitalized trauma patients","volume":"226","author":"Kay","year":"2023","journal-title":"Am J Surg"},{"key":"R28-20251212","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1160\/TH09-01-0053","article-title":"Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study","volume":"102","author":"Galanaud","year":"2009","journal-title":"Thromb Haemost"},{"key":"R29-20251212","doi-asserted-by":"crossref","first-page":"I22","DOI":"10.1161\/01.CIR.0000078464.82671.78","article-title":"Natural history of venous thromboembolism","volume":"107","author":"Kearon","year":"2003","journal-title":"Circulation"},{"key":"R30-20251212","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/TA.0000000000002830","article-title":"Updated guidelines to reduce venous thromboembolism in trauma patients: a Western Trauma Association critical decisions algorithm","volume":"89","author":"Ley","year":"2020","journal-title":"J Trauma Acute Care Surg"}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000003094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:03:42Z","timestamp":1765548222000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000003094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000003094","relation":{},"ISSN":["0890-5339","1531-2291"],"issn-type":[{"value":"0890-5339","type":"print"},{"value":"1531-2291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}